Literature DB >> 19894022

Immunohistochemical detection of somatostatin receptor subtype 5 (SSTR-5) in cushing adenoma.

Wael Hassaneen, Daniel P Cahill, Gregory N Fuller, Nicholas B Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19894022     DOI： 10.1007/s11060-009-0048-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  10 in total

1.  Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo.

Authors:  S Nielsen; S Mellemkjaer; L M Rasmussen; T Ledet; N Olsen; M Bojsen-Møller; J Astrup; J Weeke; J O Jørgensen
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

2.  The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas.

Authors:  Dalia L Batista; Xun Zhang; Roger Gejman; Peter J Ansell; Yunli Zhou; Sarah A Johnson; Brooke Swearingen; E Tessa Hedley-Whyte; Constantine A Stratakis; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2006-08-29       Impact factor: 5.958

3.  The case of Cushing's disease imaging by SPECT examination without manifestation of pituitary adenoma in MRI examination.

Authors:  Marcin Gierach; Joanna Pufal; Stanisław Pilecki; Roman Junik
Journal:  Nucl Med Rev Cent East Eur       Date:  2005

Review 4.  Somatostatin and somatostatin receptors in Cushing's disease.

Authors:  Leo J Hofland
Journal:  Mol Cell Endocrinol       Date:  2007-11-22       Impact factor: 4.102

5.  The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

Authors:  Leo J Hofland; Joost van der Hoek; Richard Feelders; Maarten O van Aken; Peter M van Koetsveld; Marlijn Waaijers; Diana Sprij-Mooij; Christian Bruns; Gisbert Weckbecker; Wouter W de Herder; Albert Beckers; Steven W J Lamberts
Journal:  Eur J Endocrinol       Date:  2005-04       Impact factor: 6.664

Review 6.  Pituitary tumors.

Authors:  I Ciric
Journal:  Neurol Clin       Date:  1985-11       Impact factor: 3.806

7.  Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors.

Authors:  Y Greenman; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1994-02       Impact factor: 5.958

8.  Localization of pituitary adenomas by using intraoperative ultrasound in patients with Cushing's disease and no demonstrable pituitary tumor on magnetic resonance imaging.

Authors:  J C Watson; T H Shawker; L K Nieman; H L DeVroom; J L Doppman; E H Oldfield
Journal:  J Neurosurg       Date:  1998-12       Impact factor: 5.115

9.  Somatostatin receptor subtype gene expression in pituitary adenomas.

Authors:  G M Miller; J M Alexander; H A Bikkal; L Katznelson; N T Zervas; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

10.  Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis.

Authors:  R Day; W Dong; R Panetta; J Kraicer; M T Greenwood; Y C Patel
Journal:  Endocrinology       Date:  1995-11       Impact factor: 4.736
  10 in total
  1 in total

1.  Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma).

Authors:  Benxia Yu; Zhongsheng Zhang; Hao Song; Yuchun Chi; Chunling Shi; Miao Xu
Journal:  Med Sci Monit       Date:  2017-04-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.